Startups
Libra Therapeutics
Develops small-molecule therapies for neurodegenerative diseases by restoring lysosomal function and autophagy and reducing toxic protein accumulation. Its research targets ALS, frontotemporal dementia and other neurological disorders.
Team
 Casey CunninghamDirector |
Clotilde Lagier TourenneScientific Adviser |
Daguang WangDirector |
Don ClevelandScientific Adviser |
Fei ShenDirector |
Gene KinneyBoard Chairman |
John RavitsScientific Adviser |
John RengerScientific Adviser |
 Lin NingBoard Observer |
Lori GoughDirector |
Martin GillCSO |
Shawn ScrantonCEO and President |
Stefan LohmerDirector |